7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025
Conference
Event
-
March 17, 2025
genOway's presentation on Wednesday, March 26, 2025 | 4 p.m. EDT:
How to enhance predictability of Treg-directed therapies in preclinical models:
- Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Demonstrating the recruitment of human Treg cells to the affected area, as well as their activation status
- Showcasing T-dependent inflammatory diseases modelling in genO-BRGSF-HIS mice
7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe